FAQ about the AMAS Test
The AMAS®TEST is a simple blood test which measures serum levels of AMA (Anti-Malignin Antibody) found to be elevated in most patients with a wide range of active non-terminal malignancies.

The AMAS® Cancer Test
An innovative aid in early cancer diagnosis and followup

This study is designed to determine the efficacy of the LifeOne on terminal cancer patients. Efficacy is to be determined by remission only. CEA, PSÁ, CA125 and other specific antigen tests will be used when possible to help verify remission. However, AMAS testing in the normal range will be the only accepted final test to determine remission. Other testing to be completed will be CBC, Comprehensive Metabolic and Lymphocyte Subset Panel (lymphocyte immunophenotype enumeration) including Natural Killer Cell Functional Assay. These tests will determine the effect of LifeOne on the immune system as well as verify the AMAS results.
Candidates for the research must have undergone biopsy to verify malignancy. CBC's with all immune markers in the normal range will be required to determine validity of the AMAS test.
Prior use of chemotherapy or radiation will not disqualify participants. However, all patients must have been without other therapies for at least 3 months prior to beginning the study, and must show active cancer.

Dosage for all people using LifeOne should be the same.

1. One half fluid ounce or 15 ml. three times daily. This will last for one year.
2. All people using LifeOne should be instructed to eliminate sugar and simple carbohydrates from their diet.
3. All people using LifeOne should be instructed to exercise regularly if able.
All people using LifeOne responses will be recorded.
5. All test results will be recorded.

Other cancer patients who wish to participate in the research will be treated with the same protocol.


Because the A.M.A.S. is an actual antibody test, it requires that the body be able to manufacture antibodies for accurate results. I have found that lymphocyte subset panels, that show the patient within the reference range, produce a consistent and accurate AMAS reading.
However, patients with lymphocyte subset panels which range in the lower third of the subset ranges produce borderline AMAS test results in many cases. As the immune system improves, as demostrated by the lymphocyte subset panel, the AMAS reading becomes a reliable indicator and shows a positive finding for cancer. This does not mean the cancer has worsened. It simply means that immune system has become more able to produce antibodies to malignan. Within 6-8 weeks after this increase in the A.M.A.S., the A.M.A.S. test results should show a steady decline to a normal range. This will occur as the subset panel shows movement toward the upper third of the reference range.

The most valuable tool in evaluating the efficacy of treatment is clinical observation. Most patients will respond within a week, showing decreased pain, increased energy, and a general feeling of increased vigor. It is important to take careful clinical notes on the patient's general feelings and how they present themselves.
If patients are currently on pain medication, as the pain decreases, it is important to decrease the pain medication. All pain medications have side effects, and may inhibit absorption of needed phytochemicals. Opiates have been shown to increase some cancers' growth and metastasis. If opiates are required for patient comfort, they may be prescribed . However, decrease as the pain decreases.

Palpate breast tumors regularly. Dramatic decreases in tumor size within a 2-week period are very common. It is also common to have breast tenderness decrease or disappear altogether, within a week or two. It is important to have CT scans for verification of both presence and regression of breast tumors.

Pictures of skin lesions including basal cell and squamous cell carcinomas are important. They will often fall off in a period of 10-30 days. Digital photos of many cases will be helpful. They must be taken before any therapeutic intervention.

Glucose IV's are contraindicated with cancer patients. I realize this goes against common practice, but research dictates that if vitamins or minerals need a medium for dissolution, a saline solution is preferred.
Do not raise the serum glucose levels artificially.
Digestive enzymes are very helpful in many cases, especially when digestive problems are present.



Statements on this website have not been evaluated by the Food and Drug Administration,
aka “FDA” and are not intended to diagnose, treat, cure, or prevent any disease or illness.